Sapirstein James (CIK 0001559509)

Latest company ownership

Shares held
492,819
Last filed at
Jan 5, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
Shares held
35,816
Last filed at
Jul 3, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 2, 2024 Jul 3, 2024 Entero Therapeutics, Inc. CEO Sell 47.5 -1,289 -3.47% ✗ $1.4K
Apr 1, 2024 Apr 3, 2024 Entero Therapeutics, Inc. CEO Sell 52.5 -174 -0.47% ✗ $735.9
Mar 15, 2024 Mar 19, 2024 Entero Therapeutics, Inc. CEO Sell 47.5 -1,887 -4.82% ✗ $9.4K
Jan 12, 2024 Jan 17, 2024 Entero Therapeutics, Inc. CEO Sell 52.5 -166 -0.42% ✗ $697.2
Oct 4, 2023 Oct 6, 2023 Entero Therapeutics, Inc. CEO Sell 47.5 -2,764 -7.64% ✗ $801.6
Jul 3, 2023 Jul 5, 2023 Entero Therapeutics, Inc. CEO Sell 47.5 -3,349 -8.48% ✗ $5.2K
Apr 3, 2023 Apr 5, 2023 Entero Therapeutics, Inc. CEO Sell 47.5 -3,347 -7.81% ✗ $8.4K
Feb 18, 2016 Feb 18, 2016 Hepion Pharmaceuticals, Inc. CEO Buy 91.3 +10,000 333.33% ✗ $10K
Nov 30, 2015 Dec 1, 2015 Hepion Pharmaceuticals, Inc. CEO Buy 90.0 +500 20.00% ✗ $1.1K
Nov 23, 2015 Nov 24, 2015 Hepion Pharmaceuticals, Inc. CEO Buy 90.0 +2,500 100.00% ✗ $4.1K